Mo will be speaking at ACR Convergence 2025 in Chicago (Sunday, Oct 26) as part of the basic science session, “Bullseye! What’s the Target for T‑Cell‑Directed Therapies?” He’ll be sharing recent work on antigen discovery and how high-resolution epitope mapping is helping us better understand T cell, driven disease mechanisms, and where that could take us in terms of new therapies.
https://rheumatology.org/annual-meeting-abstract-submission
